Insights from 2023 ESMO Annual Meeting
A

ESMO 2023 Insights: "First Survival Data From the NIPU Trial - Evaluating Nivo & Ipi Combined With UV1 Vaccination as 2L Treatment for Malignant Mesothelioma"

By Insights from 2023 ESMO Annual Meeting FEATURING Aslaug Helland
By Insights from 2023 ESMO Annual Meeting FEATURING Aslaug Helland
64 views
November 8, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
04:35
Total Health

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Feat. J. Bauman
15:37
ImmunoTherapy Bridge 2023

What’s New in NSCLC & Mesothelioma Immunotherapy

Feat. A. Morabito
08:14
2023 Texas Lung Cancer Conference Coverage

Updates in Malignant Pleural Mesothelioma

Feat. M. Marmarelis
05:16
Scripps MD Anderson Cancer Center

Recent Updates on Chemo +/- IO in Mesothelioma

Feat. R. Natale
22:02
OncoAlert

Significant Advances in Mesothelioma

Feat. G. Mountzios
09:04
Oncology Data Advisor

Discovering Research Advances in Mesothelioma

Feat. S. Kareff, E. Rodriguez
09:57
ILCC 2022 Conference Coverage

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

Feat. P. Baas
05:39
GRACE

ASCO® 2023 Insights: "Chemo +/- IO for Mesothelioma"

Feat. J. West, C. Lovly, A. Addeo
05:22
ecancer

ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …

Feat. S. Peters
04:33
ecancer

ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable A…

Feat. P. Bradbury
08:40
Laura Ridolfi

MESOVAX Clinical Trial of Pembro & Dendritic Cell Vaccine in Adv…

09:56
2020 Virtual ESMO Review

2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…

Feat. M. Dietrich
16:56
WCLC 2022 Conference Coverage

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…

Feat. M. Jakopovic
17:52
Memorial Sloan Kettering Cancer Center

Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on A…

Feat. M. Zauderer
21:36
2021 Virtual ESMO Review

ESMO 2021 Highlights on Stage III NSCLC and Malignant Mesothelioma: …

Feat. T. Owonikoko
21:39
2021 Virtual ESMO Review

ESMO 2021 Q&A Panel Discussion on Lung Cancer

Feat. I. Dagogo-Jack, T. Owonikoko
05:47
GRACE

ASCO Roundtable on 2L Malignant Pleural Mesothelioma: How Encouragin…

Feat. J. West, H. Yu, D. Spigel
07:16
WCLC 2022 Conference Coverage

WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + …

Feat. L. Huaqing Douma
32:08
Olga Olevsky

Update on Mesothelioma: The Role of VEGF, Position of Immunotherapy,…

05:13
GRACE

Does Immunotherapy Have Activity in Malignant Pleural Mesothelioma?

Feat. M. Das